Endocrine treatment in Duchenne muscular dystrophy - current practices and future directions
- PMID: 40223537
- DOI: 10.1515/jpem-2025-0171
Endocrine treatment in Duchenne muscular dystrophy - current practices and future directions
References
-
- Sodero, G, Cipolla, C, Rigante, D, Arzilli, F, Mercuri, EM. Pubertal induction therapy in pediatric patients with Duchenne muscular dystrophy. J Pediatr Endocrinol Metab 2025;38:781–7. https://doi.org/10.1515/jpem-2025-0061 . - DOI
-
- McCarrison et al.. The use of bisphosphonate and testosterone in young people with Duchenne muscular dystrophy: an international clinician survey. Manuscript ID: JPEM.2025.0039.
-
- Birnkrant, DJ, Bushby, K, Bann, CM, Apkon, SD, Blackwell, A, Brumbaugh, D, et al.. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management [published correction appears in Lancet Neurol. 2018 Jun;17(6):495. 10.1016/S1474-4422(18)30125-X.]. Lancet Neurol 2018;17:251–67, https://doi.org/10.1016/s1474-4422(18)30024-3 . - DOI
-
- Birnkrant, DJ, Bushby, K, Bann, CM, Alman, BA, Apkon, SD, Blackwell, A, et al.. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol 2018;17:347–61. https://doi.org/10.1016/S1474-4422(18)30025-5 . - DOI
Publication types
LinkOut - more resources
Full Text Sources